Earnings season started off well for the Dow Jones Industrial Average (DJINDICES: ^DJI ) yesterday with Alcoa's (NYSE: AA ) beat, and the blue-chip index is back on the upswing today. Almost the entire Dow is in the green as the index pulls in gains of 85 points as of 2:20 p.m. EDT. Alcoa ranks near the bottom of the index despite its strong quarterly report, but several big movers at the top of the index are fueling Dow investors' optimism. Let's check out the movers and shakers of the day.
Alcoa's earnings highs and low
Aluminum producer Alcoa posted quarterly earnings per share of $0.07, beating projections by a penny. More pertinent, however, revenue continued to slide in line with an industrywide trend, down almost 2% for the quarter -- although it still narrowly beat analyst projections. The company's primary-metals business was the culprit behind sliding sales and stunted earnings, as the unit posted a $32 million loss that almost negated the profit posted by the company's other divisions. However, Alcoa still expects global aluminum demand to rise as much as 7% overall for the year. Shares haven't reacted so well today, however: Alcoa's stock is down about 0.3% so far.
5 Best European Stocks To Buy For 2015: Decision Diagnostics Corp (DECN)
Decision Diagnostics Corp., formerly instaCare Corp., incorporated on March 2, 2001, is a prescription and non-prescription diagnostics and home testing products distributor. The Company distributes brand name prescription and non-prescription diagnostics products, as well as several lines of ostomy, wound cares and post-surgery medical products. The Company through its subsidiaries, PDA Services, Inc. and Decision IT Corp. offers information technology solutions in several medical cares market channels by providing physicians with information at the point of care. The Company's retail prescription business maintains three operating units, which include Licensed wholesale prescription drug distribution business; Licensed distribution of diabetes diagnostics and supplies; and Internet pharmacy/prescription fulfillment.
The Company's software is designed to integrate point of service applications. The Company is also a developer of products that offer solutions in medical care and management by providing physicians with essential information instantaneously as they meet with their patients. In addition, the Company markets its MD@Hand and MD @Work software application, which also leverages the connectivity of smart cell phones devices through the Internet. The Company's applications run on smart phones manufactured by Apple, Palm, Motorola and Samsung.
Advisors' Opinion:- [By Bryan Murphy]
Over the past few weeks, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) and Decision Diagnostics Corp. (OTCBB:DECN) have dominated the diabetes diagnostics and diabetes treatment landscape. Shares of LXRX jumped 20% on Tuesday following news that one of the key drugs in its pipeline showed more than enough efficacy in its clinical trials. DECN shares are up more than 250% on the heels of an almost-assured victory in its patent lawsuit against industry giant Johnson & Johnson (NYSE:JNJ). Anyone looking for a new trade in the diabetes diagnostics space, however, may want to look past overbought Lexicon Pharmaceuticals and Decision Diagnostics at this point, and instead turn their attention to newly-budding Neurometrix Inc. (NASDAQ:NURO).
10 Best Prefered Stocks To Watch For 2014: Boise Cascade Co (BCC)
Boise Cascade Company, formerly Boise Cascade, L.L.C., incorporated on July 26, 2004, is a vertically-integrated wood products manufacturer and building materials distributor with operations throughout the United States and Canada. The Company operates in two segments: wood products segment and our building materials distribution segment. The Company manufactures engineered wood products, plywood, lumber, and particleboard and distributes a line of building materials, including wood products manufactured by the Company�� wood products division. The Company�� products are used primarily in new residential construction, residential repair and remodeling projects, light commercial construction and industrial applications. In September 2013, the Company announced that it has completed the acquisition of Wood Resources LLC's Southeast Operations, which include Chester Wood Products LLC and Moncure Plywood LLC.
Wood Products
The Company�� wood products segment is a manufacturer of engineered wood products (EWP) and plywood in North America. It manufactures LVL, I-joists and laminated beams and also produces plywood, studs, particleboard and ponderosa pine lumber, a lumber grade sold primarily to manufacturers of specialty wood windows, moldings and doors. Most of its wood products are sold to wholesalers, including its building materials distribution segment, home improvement centers, retail lumberyards and industrial converters.
Building Materials Distribution
The Company is a wholesale distributor of building materials in the United States. Its nationwide network of 31 strategically-located distribution facilities sells a line of building materials, including EWP, oriented strand board OSB), plywood, lumber and general line items, such as framing accessories, composite decking, roofing, siding and insulation. It also operates a truss manufacturing plant located in Maine. Its products are used in the construction of new residential housing,! including single-family, multi-family and manufactured homes, repair and remodeling projects and the construction of light industrial and commercial buildings.
The Company markets its products primarily to retail lumberyards and home improvement centers that then sell the products to end customers, who are typically professional builders, independent contractors and homeowners engaged in residential construction projects. It also markets its products to industrial converters, which use its products to assemble windows, doors, agricultural bins and other products used in industrial and repair and remodel applications. The Company has more than 4,500 customers, which includes a diverse mix of wholesalers, home improvement centers, retail lumberyards and industrial converters. The Company supplies its customers through 49 located facilities (consisting of 18 manufacturing facilities and 31 distribution facilities).
Advisors' Opinion:- [By Blake Bos]
Investors searching for a lucrative investment to capitalize on a continued rebound in housing may have found the process to be quite precarious, as many companies have experienced significant run-ups in stock price. While most company valuations appear frothy,�Boise Cascade (NYSE: BCC ) �stands out as a possible cheaper alternative. In the video below, analyst Blake Bos shows you how to ask the right questions when deciding to invest and draws some valuable comparisons to competitor�Weyerhaeuser� (NYSE: WY ) .�
10 Best Prefered Stocks To Watch For 2014: Sovereign Lithium Inc (SLCO)
Sovereign Lithium, Inc., formerly Great American Energy Inc., incorporated on February 22, 2007, is a mineral exploration and development company focused on supporting clean energy and clean technology industries. The Company is engaged in identifying, acquiring and developing mineral assets in the United States and surrounding countries. The Company�� portfolio of projects primarily targets lithium production with a sub-focus on rare earth elements (REE).
The Company�� project includes Big Smoky Valley lithium project and Bear Creek REE project. Big Smoky Valley lithium project is located in Esmeralda Country in Nevada. It represents 48 unpatented placer mining claims consisting of 7,680 acres (3,108 hectares) in and around Esmeralda Country, Nevada. Bear Creek REE project consists of 10 mining claims totaling 7,311 acres (2,959 hectares) in British Columbia, Canada.
Advisors' Opinion:- [By John Udovich]
Small cap OTC stocks Sovereign Lithium Inc (OTCMKTS: SLCO), Life Stem Genetics Inc (OTCMKTS: LIFS), Nevada Gold Corp (OTCMKTS: NVGC), Guar Global Ltd (OTCMKTS: GGBL) and Makism 3D Corp (OTCMKTS: MDDD) all saw their trading halted late last year by the SEC, but now all of these stocks are trading again. So what's going on and why the sudden crackdown? First, here is a quick look at what happened to the following five small cap stocks:
- [By James E. Brumley]
Well, as it turns out, the snake that bit L&L Energy, Inc. (NASDAQ:LLEN) and Sovereign Lithium Inc. (OTCMKTS:SLCO) didn't end up biting Makism 3D Corp. (OTCMKTS:MDDD). And in retrospect, that's probably how it should be. Indeed, the fact that MDDD didn't even come close to suffering the same fate as SLCO or LLEN did may be the biggest assurance Makism 3D fans could hope for that the company is everything it says it is.
10 Best Prefered Stocks To Watch For 2014: 3D Systems Corp. (DDD)
3D Systems Corporation, through its subsidiaries, engages in the design, development, manufacture, marketing, and servicing of 3D printers and related products, print materials, and services. The company�s principle print engines comprise stereolithography, selective laser sintering, multi-jet modeling, film transfer imaging, selective laser melting, and plastic jet printers. Its 3D printers convert data input from computer-aided design software or 3D scanning and sculpting devices to produce physical objects from engineered plastic, metal, and composite print materials. The company also blends, markets, sells, and distributes various consumables, engineered plastics, metal materials, and composites; and offers various software tools, as well as pre-sale and post-sale services, including applications development, installation, warranty, and maintenance. In addition, it provides custom parts services, such as precision plastic and metal parts service and assembly capabilit ies. The company markets its stereolithography materials under the Accura and RenShape; laser sintering materials under the DuraForm, CastForm, and LaserForm; and materials for professional printers under the VisiJet brands. It primarily serves manufacturers of automotive, aerospace, computer, electronic, defense, education, consumer, energy and healthcare products, as well as original equipment manufacturers, government agencies, universities, and independent service bureaus. The company sells its products and services through its direct sales organization, sales agents, resellers, and distributors primarily in the United States, Europe, and the Asia-Pacific region. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.
Advisors' Opinion:- [By Eric Volkman]
The previously announced common stock issue from 3D Systems (NYSE: DDD ) now has a price tag. That offering will hit the market at $40.00 per share in an underwritten public flotation. Of the 7.5 million shares being sold, just over 6.18 million are being offered by the company, and 1.32 million will come from existing shareholders, including "certain officers and directors and their affiliates."��
10 Best Prefered Stocks To Watch For 2014: Danske Bank A/S (DANSKE)
Danske Bank A/S (the Bank) is a Denmark-based bank. Its operations are divided into five business segments: Banking Activities caters to personal and business customers, comprising finance centers, mortgage finance operations and real estate agency operations, as well as property finance operations; Danske Markets and Treasury is responsible for the Bank�� activities in the financial markets, such as trading in fixed income, foreign exchange, equities and interest-bearing securities, as well as equity portfolios, among others; Danske Capital is engaged in the development and marketing of wealth management products and services; Danica Pension encompasses the Bank�� activities in the life insurance and pensions market; Other Activities encompasses the Bank�� real estate activities and support functions, as well as the elimination of returns on own shares and bonds. Is operational in 15 countries, with emphasis on the Nordic region. Advisors' Opinion:- [By Namitha Jagadeesh]
Kabel Deutschland Holding AG rose to a record after getting an offer from Liberty Global Plc. Aveva Group Plc (AVV) jumped 5.4 percent as Citigroup Inc. upgraded the shares. Danske Bank A/S (DANSKE) dropped 6.1 percent after Denmark�� financial regulator ordered it to increase its risk-weighted assets. Royal Imtech NV fell to the lowest price since 2004 after posting a first-quarter loss on costs relating to a fraud investigation.
10 Best Prefered Stocks To Watch For 2014: LyondellBasell Industries NV(LYB)
LyondellBasell Industries N.V. manufacturers and sells chemicals and polymers, refines crude oil, produces gasoline blending components, and develops and licenses technologies for production of polymers. The company?s Olefins and Polyolefins segment offers olefins, including ethylene, propylene, and butadiene; aromatics, such as benzene and toluene; polyolefins, which comprise polypropylene (PP), high-density polyethylene, low-density polyethylene, and linear low-density polyethylene; specialty polyolefins, including catalloy process resins, PP compounds, and polybutene-1 resins; and ethylene derivatives, which comprise ethanol. Its Intermediates and Derivatives segment provides propylene oxide (PO); PO co-products, including styrene monomers and TBA derivative isobutylene; PO derivatives, such as propylene glycol, propylene glycol ethers, and butanediol; acetyls, such as methanol, acetic acid, and vinyl acetate monomers; ethylene derivatives, which comprise ethylene oxide , ethylene glycol, and ethylene glycol ethers; and flavor and fragrance chemicals. The company?s Refining and Oxyfuels segment offers gasoline and components, ultra low sulfur diesel, jet fuel, and lube oils; diesel, feedstock, fuel oil, gasoline, and bitumen; and gasoline blending components, including methyl tertiary butyl ether, ethyl tertiary butyl ether, and alkylate. Its Technology segment develops and licenses polyolefin and other process technologies. This segment also develops, manufactures, and sells polyolefin catalysts, as well as provides technology services, which comprise safety reviews, training and start-up assistance, engineering services for process and product improvements, and manufacturing troubleshooting. LyondellBasell Industries N.V. has operations in the Americas, Europe, Asia, and internationally. The company was founded in 2005 and is based in Rotterdam, Netherlands. LyondellBasell Industries N.V. is a subsidiary of Prochemie GmbH.
Advisors' Opinion:- [By John Kell]
LyondellBasell Industries N.V.(LYB) said its fourth-quarter earnings soared 86% as the plastics and chemicals company reported better profitability across all key business segments. Results were far better than Wall Street expected, sending shares up 2.4% to $79.90 in premarket trading.
- [By Chad Tracy]
In a classic contrarian move, he purchased more shares of troubled plastics-maker LyondellBasell Industries (NYSE: LYB), even as the company was sliding toward bankruptcy.
- [By Rich Duprey]
Specialty materials-maker LyondellBasel Industries� (NYSE: LYB ) �announced yesterday�that�it was raising its quarterly dividend payment by 25%, to $0.50 per share, as well as authorizing the repurchase of up to 10% of the company's outstanding shares.
10 Best Prefered Stocks To Watch For 2014: Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.
ALDEX Line
ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.
BROVEX Line
The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.
CEDAX Line
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.
NATROBA Line
NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.
PEDIATEX Line
As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.
REZYST Line
REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.
Product Candidates in Development
Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent. - [By Michael Douglass and David Williamson]
Shares of�Pernix Therapeutics� (NASDAQ: PTX ) soared 31% yesterday after the company revealed that it had bought the U.S. rights to�GlaxoSmithKline's (NYSE: GSK ) Treximet (which helps treat migraines in adults) for $250 million upfront (and some potential additional payments later). The importance of this purchase cannot easily be overstate for Pernix -- the company had $85 million in revenue last year, while Treximet on its own brought in $79 million -- and Pernix clearly sees some additional upside potential for the drug, whether it's through a potential indication expansion (to pediatric patients) or through synergies with Pernix's current salesforce.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV).
No comments:
Post a Comment